financetom
Business
financetom
/
Business
/
Provident Healthcare Partners Advises CPS Infusion on its Partnership with Seven Hills Capital
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Provident Healthcare Partners Advises CPS Infusion on its Partnership with Seven Hills Capital
Sep 9, 2025 10:49 AM

BOSTON and NEW YORK, Sept. 9, 2025 /PRNewswire/ -- Provident Healthcare Partners ("Provident"), a leading healthcare investment banking firm, is pleased to announce its role as exclusive financial advisor to CPS Infusion ("CPS") in a transformative platform transaction with Seven Hills Capital ("SHC"). As a trusted provider of infusion services in Georgia, this partnership marks an important step in CPS' expansion and will allow the Company to broaden its offerings to new therapeutic areas and markets while continuing to deliver consistent, high-quality care.

Provident's deal team was led by Managing Directors Kevin Palamara and Scott Davis. Fox Rothschild served as legal counsel to CPS and Bass Berry & Sims served as legal counsel to SHC.

"I will be forever grateful for the expertise and dedication received from Provident Healthcare Partners in my recent business transaction. Their results driven approach, ability to anticipate challenges, and navigate complex negotiations were invaluable. From the beginning, their team demonstrated exceptional professionalism and deep industry knowledge," commented Dr. Marcus Crawford, Founder and CEO of CPS.

"CPS presented a unique investment opportunity, requiring the outlook and capabilities of an equally unique investor.  We believe we found that in the partnership created with Seven Hills and expect to see great things from the platform in the years to come," noted Scott Davis, Managing Director at Provident.

About CPS Infusion

CPS Infusion is a leading provider of infusion therapy, operating seven locations across the greater Atlanta area. The Company utilizes a patient-focused approach to providing complex biologic medical therapies to patients with chronic diseases in a comfortable outpatient environment. For more information, visit https://cpsinfusion.com/.

About Seven Hills Capital

Seven Hills Capital is an operator-centric private equity firm founded in 2016 and headquartered in Nashville, Tennessee. Driven by a value-creation mindset, Seven Hills serves as a committed capital and strategic partner to entrepreneurs and management teams building differentiated healthcare services businesses. Seven Hills Capital exclusively targets niche, practitioner‑led ventures, particularly those serving complex or underserved sectors with defensible and innovative business models. In December 2023, the firm closed its inaugural fund of $125 million, underscoring its commitment to building lower‑middle‑market healthcare platforms with scale potential. For more information, visit https://www.7hillscap.com/.

About Provident Healthcare Partners

Provident is a leading healthcare investment banking firm specializing in merger and acquisition advisory, strategic planning, and capital formation services for healthcare companies. The firm has a comprehensive knowledge of market sectors and specialties, including infusion care.  Provident also has unsurpassed experience and insight into the M&A process, which includes working with a multitude of investors such as private equity firms and strategic consolidators. For additional information, visit www.providenthp.com or follow Provident on LinkedIn.

Contacts:         

Provident Healthcare Partners
Kevin Palamara
617-226-4221
[email protected]


 

Scott Davis
617-226-4259
[email protected]

View original content to download multimedia:https://www.prnewswire.com/news-releases/provident-healthcare-partners-advises-cps-infusion-on-its-partnership-with-seven-hills-capital-302551304.html

SOURCE Provident Healthcare Partners LLC

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sylvamo's Q1 Adjusted Operating Earnings, Revenue Drop
Sylvamo's Q1 Adjusted Operating Earnings, Revenue Drop
May 26, 2025
07:13 AM EDT, 05/09/2025 (MT Newswires) -- Sylvamo ( SLVM ) reported Q1 adjusted operating earnings Friday of $0.68 per diluted share, down from $1.07 a year earlier. Three analysts polled by FactSet expected $0.69. Revenue for the quarter ended March 31 was $821 million, down from $905 million a year earlier. Three analysts surveyed by FactSet expected $815.9 million....
AngloGold Ashanti's Q1 Headline Earnings, Revenue Rise
AngloGold Ashanti's Q1 Headline Earnings, Revenue Rise
May 26, 2025
06:35 AM EDT, 05/09/2025 (MT Newswires) -- AngloGold Ashanti ( AU ) reported Q1 headline earnings Friday of $0.88 per diluted share, up from $0.14 a year earlier. Analysts polled by FactSet expected $0.89 Revenue for the quarter ended March 31 was $1.96 billion compared with $1.17 billion a year earlier. An analyst surveyed by FactSet expected $1.84 billion. Shares...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Docebo Reports Q1 Earnings and Revenue Beat, Forecasts 2025 Growth on AI Investments
Docebo Reports Q1 Earnings and Revenue Beat, Forecasts 2025 Growth on AI Investments
May 26, 2025
06:31 AM EDT, 05/09/2025 (MT Newswires) -- Docebo ( DCBO ) , a learning platform provider, on Friday reported a first-quarter earnings and revenues beat and forecast further growth for 2025 as it continues to investment in AI. For the three months ending March 31, the company reported adjusted net income of US$8.5 million, or $0.28 per share, compared with...
Copyright 2023-2026 - www.financetom.com All Rights Reserved